-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Praxis Precision Medicine, Maintains $810 Price Target

Benzinga·07/29/2026 10:31:02
Listen to the news
BTIG analyst Kambiz Yazdi reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $810 price target.